Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

1.8K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.8K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

3.4K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.4K
The Cell Cycle Control System01:28

The Cell Cycle Control System

3.6K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
3.6K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

5.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
5.1K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 Patients.

JACC. CardioOncology·2026
Same author

Direct Synthesis of γ-Keto Sulfones via Bro̷nsted Acid-Promoted Tandem Sulfonylation of Propargylic Esters with RSO<sub>2</sub>H.

The Journal of organic chemistry·2026
Same author

Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myeloma.

NPJ precision oncology·2026
Same author

Comparison of Patient-Reported Outcomes for Elranatamab in MagnetisMM-3 Versus Real-World Physician Choice of Therapy for Triple-Class Refractory Multiple Myeloma.

Clinical lymphoma, myeloma & leukemia·2026
Same author

Diagnosis and management of immune effector cell-associated enterocolitis after ciltacabtagene autoleucel.

Blood advances·2026
Same author

Determinants of gastrointestinal disease burden and survival in systemic AL amyloidosis.

Blood advances·2026

Related Experiment Video

Updated: Sep 27, 2025

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

8.4K

Cell cycle regulation and hematologic malignancies.

Yun Dai1, Fengyan Jin2, Wei Wu3

  • 1Laboratory of Cancer Precision Medicine, The First Hospital of Jilin University, Changchun, Jilin, China.

Blood Science (Baltimore, Md.)
|April 11, 2022
PubMed
Summary
This summary is machine-generated.

Cell cycle regulation by cyclin-dependent kinases (CDKs) and inhibitors is crucial for cell division. Dysregulation of these pathways drives cancer, making them key therapeutic targets, especially in hematologic malignancies.

Keywords:
Cell cycleCyclinCyclin-dependent kinaseHematologic malignancyTranscription

More Related Videos

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
12:03

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

Published on: July 8, 2012

18.9K
Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

9.6K

Related Experiment Videos

Last Updated: Sep 27, 2025

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

8.4K
Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
12:03

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

Published on: July 8, 2012

18.9K
Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

9.6K

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The cell cycle, comprising G1, S, G2, and M phases, is tightly controlled by cyclin-dependent kinases (CDKs) and their partners, cyclins.
  • Endogenous CDK inhibitors (e.g., p16INK4a, p21CIP1) and checkpoints ensure genomic integrity during cell division.
  • Aberrant CDK activity, driven by genetic and epigenetic changes, fuels uncontrolled cell proliferation in cancer, including hematologic malignancies.

Purpose of the Study:

  • To review the complex cell cycle regulatory network.
  • To discuss genetic and epigenetic alterations impacting cell cycle control in cancer.
  • To highlight cell cycle-related therapeutic targets in hematologic malignancies.

Main Methods:

  • Literature review of cell cycle regulation pathways.
  • Analysis of genetic and epigenetic alterations in cell cycle genes.
  • Discussion of therapeutic strategies targeting cell cycle machinery.

Main Results:

  • CDKs and cyclins drive cell cycle progression, while inhibitors and checkpoints provide negative regulation.
  • Constitutive activation of CDKs and disruption of checkpoints are hallmarks of cancer.
  • Numerous oncogenes and tumor suppressors influence cell cycle entry, progression, and DNA damage response.

Conclusions:

  • Understanding cell cycle regulation is vital for cancer therapy development.
  • Genes and proteins involved in cell cycle control represent promising targets for treating various cancers.
  • This review focuses on therapeutic opportunities within hematologic malignancies, leveraging insights into cell cycle machinery.